CTSA Program Webinar

Wednesday, March 27, 2019

2:00 – 3:00 ET

Agenda Time Topic Presenter

2:00 PM -

2:05 PM

Welcome

NCATS and CTSA Program Updates

Christopher P. Austin

& Michael Kurilla

2:05 PM –

2:10 PM

Un-Meeting: Machine Learning and AI

Applications in Translation ScienceDeborah Ossip

2:10 PM –

2:50 PM

Spring CTSA F2F Meeting Report-Outs

• Collaboration and Engagement

• Common Metrics

• Methods & Processes

• Career Professional Development for

the Clinical and Translational Science

Workforce

Louisa A. Stark

Raquel Ruiz

Don McClain

Emma Meagher and

Doris Rubio

2:50 PM –

2:55 PMCLIC Forum Martin Zand

2:55 PM -

3:00 PMWrap-Up and Adjourn

2

NCATS and CTSA Program Updates

Christopher P. Austin & Michael Kurilla

President’s Budget: NIH Budget - FY 2020

President’s Budget – FY 2020Released March 18, 2019

• NIH - $34.4 billion• $4.9 billion (12.6%) less than FY 2019

• NCATS - $694.1 million• $112.3 million (13.9%) less than FY 2019

• All NIH ICs reduced by 13.9%

• NIH OD reduced less due to increase in new researcher funding initiative

• NCATS details: https://ncats.nih.gov/about/center/budget

• Includes NCATS Director’s message & Highlights HEAL Pain Management-ERN

Next Steps• Congressional Hearings – April 2019

• Congress drafts appropriation bills and reports – Summer?

President’s Budget: NCATS Budget - FY 2020

NCATS’ Role in the HEAL Initiative: Developing Drugs and Testing Platforms for Pain, Addiction, and Overdose

NOT-TR-19-018 NCATS is accepting pre-proposal applications!

Mission: Speed and facilitate the development of new treatments for pain, opioid misuse and opioid overdose

Objective: Establish research collaborations to• Identify and de-risk potential therapies that work in novel

ways through development of assays (tests), high-throughput screening and optimization of promising compounds

• Accelerate the identification of promising chemical structures and develop those into pharmacological or drug-like compounds

• Advance promising new drug candidates through rigorous pre-clinical efficacy and safety studies for first-in-human clinical trials as required by the FDA

Productive Partnership(s)• Milestone driven• Agile and iterative • Synergistic• Mission-specific

NCATS brings: • Access to resources and

technology not easily accessible

• Automation• Industry and other

expertise• Agile process• Program management

Collaborator brings: • Target, probe, or

compound• Subject matter

expertise• Necessary resources• Existing data

Human Cell-Based Platforms for

Testing New Treatments

Stem Cell

Translation

Laboratory

3-D Tissue

Bioprinting

Laboratory

Early Translation Branch

Development of Pharmacological

Probes for Novel Targets

Therapeutic Development Branch

Development of Investigational New

Drugs for Clinical Testing

Early LatePreclinical Development

Clinical

Testing

and

Trials

Accessing NCATS Preclinical Capabilities through HEAL Collaborations

Accelerating Translation of Novel

Compounds for Clinical Testing

NCATS therapeutics development teams invite researchers to enter into research collaborations with NCATS.

• Applicants can propose collaborative projects with any of these preclinical programs

• NCATS has tools and capabilities that can help researchers without translational science expertise take their discoveries to the next level

• IP is typically licensed to partner with terms that aren’t burdensome

*Cycle I Cycle II Cycle III

Pre-proposal March 18, 2019 July 18, 2019 November 18, 2019

Full proposal April 22, 2019 August 22, 2019 December 23, 2019

**Notification from NCATS June 1, 2019 October 1, 2019 February 1, 2020

Visit https://ncats.nih.gov/heal/funding/call-for-proposals for proposal instructions!

NOT-TR-19-018 Key Dates

*Proposals submitted within the first cycle will be considered for implementation on a rolling basis.

**Notification whether the full proposal will enter into discussions with NCATS scientists to make a final determination of feasibility, alignment of goals, and project plan with milestones and go/no-go decisions.

Challenge 1: Integrated Chemistry DatabaseChallenge 2: Electronic Synthetic Chemistry Portal Challenge 3: Predictive Algorithms Challenge 4: Biological AssaysChallenge 5: Integrated Solution

For Challenges 1-4, up to 5 winners per Challenge will receive $100,000For Challenge 5, up to two winners will receive $500,000

NCATS ASPIRE (A Specialized Platform for Innovative Research Exploration) Overview of Design Challenges for Translational Innovation in Pain, Opioid Use Disorder and Overdose

• Submit your solutions by May 31, 2019• Find details at https://ncats.nih.gov/aspire/challenges• Sign up for email updates at NCATSASPIREChallenge@mail.nih.gov• Join the conversation on Twitter using #NCATSASPIRE The NCATS ASPIRE Challenges are a component of the

NIH HEAL (Helping to End Addiction Long-termSM) Initiative:https://www.nih.gov/heal-initiative

NCATS / Eli Lilly Externship: Apply Now!

10

Objective

• Promote experiential rotation opportunities for CTSA

investigators and trainees in “real world,” private

sector setting

Program Characteristics

• Embedded in functional teams, mentoring by Eli Lilly

scientists

• 6 months, based in Indianapolis at Eli Lilly

• Shared funding between NCATS and Eli Lilly

Examples of Projects (2016-2018 cohorts)

• Mechanistic Modeling of the Tau Pathway in

Alzheimer’s disease

• Translational pharmacology of diabetes

• FDA approval process for a new oncology drug

Featured above: Christopher P. Austin, M.D., Director,

NCATS; Joan Nagel, M.D., M.P.H., Medical Officer,

Division of Clinical Innovation, NCATS; Danise

Subramaniam, Ph.D., Senior Director, Global Regulatory

Affairs-NA Eli Lilly and Company; Josephine Taverna,

M.D., NCATS Eli Lilly Scholar;

Michael Kurilla, M.D., Ph.D., Director, Division of Clinical

Innovation, NCATS

2019 Cycle anticipated start date July 2019. Applications due by April 16, 2019.

https://ncats.nih.gov/ctsa/training/resources/lilly-externship

(live video vignette of Dr. Taverna now on NCATS website)

Contact: Joan Nagel, M.D., M.P.H. joandav@mail.nih.gov

Funding Opportunity Announcement for Administrative Supplements for Research on Bioethical Issues

(PA-19-217)• Purpose:

• The National Institutes of Health (NIH) Office of Science Policy within the NIH Office of the

Director (OD) published a Funding Opportunity Announcement for administrative supplements to

support research on bioethical issues to inform future policy directions or embed bioethics within

NIH-supported research. Applicants may propose to supplement parent awards focused on

bioethics or to add a component related to bioethics to a parent award in which bioethics was not

the focus.

• Funding Information:

• Estimated Total Funding: TBD

• Expected Number of Awards: 10

• Estimated Award Ceiling: Up to $100,000 direct costs for 1 year

11

2019 Fall CTSA Program Meeting

• Date: September 26 – 27, 2019

• Place: Hyatt Regency Crystal City at Reagan National Airport, Arlington VA

• https://clic-ctsa.org/events/2019-fall-ctsa-program-meeting

• Tentative Agenda

12

THURSDAY, SEPTEMBER 26

9:00 a.m. – 6:00 p.m. CTSA Program Steering Committee Meeting*

12:00 – 5:00 p.m. Administrators Meeting

5:00 – 7:30 p.m. Hub Poster Session**

FRIDAY, SEPTEMBER 27

8:00 a.m. – 5:00 p.m. Full Day Fall CTSA Program Meeting

*Included on the agenda for reference only. Open to CTSA Program Steering Committee members only.

** One poster per hub.

Submit your suggestions through May 1!

13

Submit topics through the CLIC Suggestion

Box:

Use the drop-down “Suggestion for CTSA

Program Meeting”)

https://clic-ctsa.org/contact/suggestion-box

CLIC Un-Meeting: Registration Now Open!

Register by May 13 to reserve your spot (space is limited)

Learn more:

http://bit.ly/CLIC_unmeeting_2019

Register:

https://is.gd/CLIC2019_Un_Mtg_Regn

Collaboration/ Engagement DTF Face-to-Face MeetingLouisa A. Stark

NCATS/ Workgroup Updates• Measuring Community Engagement Discussion Group – Established

January 2019

• Focus: Discuss high level aspects and logistics of measuring engagement.

• To join this open group: email patricia.jones@nih.gov.

• Health Disparities Workgroup

• Mission: To better align the individual CTSA Program hubs, understand the current

landscape of health disparity efforts within and outside of CTSA Program hubs, and

facilitate connections between hubs and local, state and national efforts.

• Plan: Conduct a nationwide landscape analysis to create a list of existing activities

that can link CTSA Program hubs with local, state, and national translational health

disparity efforts.

• To join: email collaboration_engagement_dtf@clic-ctsa.org or request to join at

https://clic-ctsa.org/groups/health-disparities.

Table Discussions: Identified topics of interest for workgroups or discussion groups beginning in 2020.

• Community Engagement Competencies as Metrics

(How to Train, How to Measure)

• Create curriculum around the CE competencies

established by CE/WD Joint Workgroup

• Identifying and/or developing practical tools for

integrating bi-directional community/ stakeholder

engagement into team science

• Concept Analysis of Community Engagement

• Integrating bi-directional community/ stakeholder

engagement across the clinical and translational

research mission (including education, research &

policy)

• Identify & address unconscious bias in context of

CE research

• Capacity building for bi-directional community

research

• Identify common elements of successful models of

community engagement across the CTSA

consortium (by stakeholder group, region) –

conduct an environmental scan, to identify models,

tools, etc.

• Develop and evaluate new processes to assure

community/ patient perspective is included in

multicenter trials with a single IRB

• Define impact of community-engaged research

• In reach (back to your institution) for community

driven projects

• Addressing challenge of community priorities

that don’t match researchers’ interests/ funding

One-Minute Presentations from Members

• 16 members shared a:

• Best practice

• Resource

• Innovative approach

• Program

• Challenge they wished to discuss with others

• Call for partners/collaborators on a project

• Followed by table discussions with other members who were

interested in learning more

Common Metrics Initiative Session HighlightsRaquel Ruiz

The session focused on:

1. Providing an overview of the Common Metrics Initiative 2.0 Assessment and the key feedback pointsa. Engaged in a conversation of how to move forward

2. Facilitating a discussion on the overall activities of the Common Metrics Initiative and what is on the horizon

CMI 2.0 Assessment Objectives

• Take a pulse on how well the metrics are implemented and utilized at each hub

• Engage with the consortium on ways to improve the metrics and the initiative overall

• Determine a process on how to move progressively forward with the initiative with the goal of measuring how well the consortium is doing as a collective across the metrics

Key Feedback PointsCMI 2.0 will focus on four areas:

1. Determine overall approach or concept for metrics

2. Establish a plan for development/prioritization of new and refinement of existing metrics

3. Refining Common Metrics processes

4. Common Metrics reporting improvement

2.0 Small Group Discussion2.0 Feedback Points:

1. What should be the overarching approach that guides the Common Metrics Initiative?a. One per core vs. Key aspects of CTR vs. Metrics of what we

are doing well vs. Metrics that assess Consortium performance

2. What are approaches for how to work on metrics that may fall outside a hub's direct influence?

Overall CMI Group Discussion

• What has been your most successful strategy with implementing the CMI at your hub? (ex. forming metric teams, data management, developing your TTC, achieving metric strategic management improvements, etc.)

• What worked? Why?

• Separating the quantitative data reporting from the narrative reporting (TTC plan) would allow for timelier reporting back to hubs, what are your concerns or questions about this change? (ex. March 31st due date for numerical data and August for TTC plans)

On the Horizon

• Median Accrual Ratio Metric Operational Guidelines

• Informal discussions on a Community Engagement metric

• Expressions of Interests• Dissemination, Implementation, Knowledge & Translation

sub-group:

• developing, refining and testing basic metrics

• Team Science Affinity Group: Team Science Competencies

Common Metrics Webpage

Menu Items:• All Common Metrics• Common Metrics Reporting• Common Metrics FAQs• CM Executive Committee• Common Metrics Forum• Submit Story from the Field

Contact us @ common_metrics@clic-ctsa.org

The Methods & Processes Domain Task Force Face to Face Meeting

Don Mcclain

Methods and Processes DTF: Publication from Workgroup on Use of the EHR to Support Recruitment of Research Subjects

Jihad S. Obeid, Laura M. Beskow, Marie Rape, Ramkiran Gouripeddi, R. Anthony Black, James J. Cimino, Peter J. Embi, Chunhua Weng, Rebecca Marnocha, and John B. Buse, for the Methods and Process and Informatics Domain Task Force Workgroup‡

A survey of practices for the use of electronic health records to support research recruitment.

J Clin Trans Sci (2017) 4:246

Points out lack of “best practices,” and calls for research trials to determine optimal approach to using the EHR for recruitment.

29

Readiness for Team Science Work GroupDeborah DiazGranados, VCU; Dayan Ranwala, MUSC; Susan McHale; Eric Schienke; Arthur Blank, et al.; Rebecca Moen, Past Co-Chair

1. Great Team Science Contest: 170 stories submitted,

reviewed and winners recognized at the Fall ’18 Meeting

2. Reviewed P&T policies in terms of recognition of

Team Science and resource sharing at 49 CTSA hubs:

Found wide variety of practices, manuscript in preparation.

Held two forums, each held at PhRMA Foundation and attended by

over 40:

2017:

• “Regulatory Interfaces Surrounding the Growing Field of

Additive Manufacturing of Medical Devices and Biologic

Products” (3D printing)

• “The Integration of Emerging Omics and Approaches to Advance

Precision Medicine: How Can Regulatory Science Help?”

2018: Digital health discussed key issues including:

- Data (interoperability, standards, quality, provenance, curation)

- Moving from data to evidence (validation, modeling, use in regulation)

- Specific issues for devices (and re-purposing of non-medical devices

for medical use)

- Broader policy issues (security, privacy, incentives, international

considerations)

Manuscripts in preparation

Regulatory Science to Advance Precision Medicine Working Group

Scott Steele, PhDUniversity of Rochester

Joan Adamo, PhDUniversity of Rochester

Discussion of Areas of Interest for future Workgroups

1. Develop Team Science Competencies: Proposal for workgroup being developed, could be completed before “sundowning” of the current DTF structure

2. Growing out of the recruitment using the HER work: Establishing best practices in the integration of programs that contribute to Recruitment of Research Subjects (e.g. Integrating Special Populations, Patient and Clinical Interaction, Network Capacity, Community).

3. Could we develop a common pilot award platform that would facilitate cross CTSA pilot awards?

April 8th Webinar – RBA Tools Register for the webinar, click here

Resources

Career Professional Development for the Clinical and Translational Science Workforce- A joint meeting for Workforce Development, KL2 & TL1 Directors

Emma A Meagher

Agenda• WFD DTF

• Ignite Presentations

• Measures of Impact

• KL2• StarWork Taskforce Alumni Survey

• Online IDP

• Authorship Agreement

• Career Timelines

• KL2-TL1• Integrating programs best practices

• TL1• Clinical Training of TL1 Trainees with KL2 Scholars

• TL1 Reps

• TL1 survey update

Workforce Development IGNITE Presentations

Using Games to Enhance Learning

ALL NIH & AHRQ Grant Apps./Prog. reports MUST focus on: 1. the scientific premise of the proposed research, 2. authentication of key biological & chemical resources 3. consideration of relevant biological variables4. rigorous experimental design – robust/unbiased results

1. New Scored Criteria 2. Additional Required Documentation3. Required Training

The Challenge

Kaizen R2T

• A four week game where weekly participants receive links to review articles/videos to prepare for upcoming questions.

• Participants, competing as teams, answer timed Qs. The quicker you answer, the higher your points.

• 180 individuals (faculty & staff) completed the Rigor, Reproducibility & Transparency game

• Players represented 13 institutions• Disseminating to other CTSA Hubs (OSU, Vanderbilt)

Experience

Goals

• Expand reach to CTSA Consortium• Collaborate in the development of new games.

CONTACT: David D. Chaplin, MD, PhDEMAIL: dchaplin@uab.edu

Team Science To Transform Training

• How to make training less theoretical, more practical, more authentic

• How to define & assess team science competencies

The Challenge

• If we expect future clinical & translational researchers to work in interdisciplinary teams, they should be trained in interdisciplinary teams

Experiential TL1 Teams & Didactic TS Course

Principles, Strategies

Evidence

Application

Experience

• Outcomes: Clinical Research Appraisal Inventory, Researcher Orientation Scale and Grit Scale

• Other Hubs: Mayo & Wisconsin

• Manuscript in Preparation

Goals

Matched Controls to Measure the Impact of

CTSA Pilot Grant Funding

• NIH Required Metrics: How many teams funded? And How many teams published results? AND Encourage cross institutional/disciplinary collaboration

• How do you know what would have happened anyway? Faculty collaborate on thousands of publications each year.

• WHAT IS THE BASELINE level of collaboration and productivity?

The Challenge

Experience

Goals

Adding team evaluation and comparison tools to open source “Profiles” research networking softwareCONTACT: Griffin WeberEMAIL: griffin_weber@hms.Harvard.edu

• Proposal teams have more diversity than typical teams that write publications, but still more familiarity than by random chance

• Funded teams published 2.5 articles citing the CTSA grant, but randomly generated matched teams published 1.0 articles

• New lasting collaborations formed even in teams that were not funded (an indirect effect of the program)

Additional TL1 program partners are welcome

CONTACT: Wayne T. McCormack, PhDEMAIL: mccormac@ufl.edu

Measuring Impact: How can we measure the Impact of our Education, Training and Workforce Development efforts beyond publications, grants and patents?

1. Multi-generation mentoring

2. F/U w/ Scholars What did we NOT train you on?

3. Measure Team Composition and Team Connectivity

4. Measure Retention of Diverse Scholars

5. Trajectory Portfolio Diversity in Research Effort

6. Culture and Structure of Institutions

7. Teamwork to Achieve the Mission

8. Measures of Collaboration

9. Measure Working in Teams

10. Level of engagement of T&K Trainees

11. T&K Professional Effort Across Institutions

12. Presentations to External/Community

13. Implementation Processes

14. Size of workforce – accelerate translation

15. Social Media – wider dissemination

16. Utilization – Novel Programs – Survey Instruments

17. Translational Milestone Achieved

18. Measure Impact in the Field

19. Movement Across Trajectory/Spectrum

20. Self-Confidence, Competencies

21. Job Satisfaction

• NEXT STEPS: CREATE REDCap Survey for members to vote.

Discussion of KL2 Alumni Survey Report

• Surveyed former recipients of KL2 funding to learn about their experiences during and after KL2 support

•

• 42% response rate with 756 unique responses received; 55% female, 44% male, 23% URP

• Participants responded positively about their experience before and after completing the KL2

• Most agreed their job is meaningful & they are satisfied with the direction of their career

• 339 respondents hold administrative / leadership roles

• Significant majority remain engaged in Science

• Robust discussion regarding next steps to analyze data carefully and prepare manuscript

38

Customized Career Development Plan

Shared the Customized Career Development plan from boththe Mentee and Mentor perspectives.

The mentee is able to set up the account. It requires some information about position, research IDs, permanent address, and login information. Once an account is established, the researcher/mentee would move onto the self-assessment, goal setting and selecting from 14 competencies. It has other functions such as adding milestones, scheduling meetings, marking a milestone complete, and a notes section.

The Trainee

The Mentor

The mentor login and functionality consists of a listing thetrainees, the trainees’ goals, upcoming milestones, and acompletion date, along with the trainee timeline for all goals.The mentor is able to enter comments on the mentee’s goals,making this online IDP program interactive.

Contact: Doris Rubio, PhD

EMAIL: dmr18@pitt.edu

Implementing an Authorship Agreement

Establish an Authorship Agreement

Contact : Colleen A. Mayowski, EdD, MLIS

EMAIL: mayowski@pitt.edu

1. Substantial contributions to the concept/ design of the work; the acquisition, analysis, or interpretation of data for the work; AND

2. Drafting the work or revising it critically for important intellectual content; AND

3. Final approval of the version to be published; AND

4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Authorship credit? Authorship order? Target journal? Roles and responsibilities? Meeting deadlines?

Contact: Katherine Hartmann, MD, PhD

EMAIL: katherine.hartmann@Vanderbilt.edu

1.Discussion included: - Planning for Success, - Strategizing timing for Grant Submission, - Having a complete scientific hypothesis including a preparation list, - Quality checks to test the feasibility of funding, and awareness of the implication for leaders.

Timelines of Grant Development

KL2 Presentations

What has worked well in integrating TL1 & KL2 Trainees? Application/Integration Shared Learnings Integration Timing/Frequency

• KL2 scholars review TL1 applications and then present in study section format

• KL2/TL1 Team projects

• Research trainee symposium

• Integrated work-in-progress

• Networking events

• Wkly Fellows Conf. Presentation

• Orientation• Talking Science to lay audiences - Posters• Journal clubs• Mentor /Mentee Training• Grant Writing workshops, Mock Reviews• Classroom experiences• Dealing with media• Presentation skills• Developing budget• Overlapping courses• Career development seminars• Team science hierarchy• Work life integration• Entrepreneurship• Coaching

• The 'integration' occurs after the KL2 folks graduate

• Integrating TL1 post-docs w/KL2 as new-peer mentors.

• Integrate inst. T32 postdoc w/then institutes K awareness

• We do not specifically try to integrate TL1 & KL2 trainers. We find the needs are very different.

• Some KL2s enroll in the Masters course work, but not required

Greatest Successes Best Practices

• Trained KL2 to be mentors to pipeline programs that led to TL1

• Greatest Success - the KL2 graduates who are TL1 mentors

• Weekly TL1 & KL2 'fellows' conference sessions with career development activities and trainee research presentations has yielded some valuable peer-mentoring relationships

• Ts & Ks present to (and receive feedback from) each other

40

A program for Clinical Training of TL1 Trainees with KL2 Scholars

The Goal

• Expose TL1 trainees to patients that are experiencing the diseases that are associated with their basic science research.

• Create an environment where trainees begin to develop an appreciation for the research process.

• Introduce trainees to mentors who can serve as translational research role models.

Structure

Experience

CONTACT: Perry V. Halushka, MD, PhDEMAIL: halushpv@musc.edu

• The trainees spend one-half day a week in clinic with a physician-scientist for a full semester.

• the TL1 trainee is paired with a KL2 scholar. • To date 25 TL1 trainees have experienced the translational

sciences clinic.

• Trainees: choose a mentor/clinic related to his/her dissertation topichave an introductory period to gain familiarity with the clinic.

• Shadow patients with the mentor.

• Perform literature searches to discover the latest concepts concerningthe patient’s disease and discuss them with their mentor.

• Are encouraged to write a review article on a topic germane to theirresearch and clinical observations with their mentor if appropriate.

TL1 Reps Views from the Ground

Accomplished

Goal

CONTACT: Simeon Abiola, PhDPhD Candidate, University of RochesterMartha Gay, PhD, Postdoctoral Scholar, Georgetown University

• Created GroupMe account, Twitter (@TL1Scientist), LinkedIn Group, Interactive Newsletter (each semester), Webinar, hype out for submissions to create/design the group logo, Website with activities, etc.

• Grant for scholarly exchange (75k grant) Best Practice URMC has a RCMI grant; URP travel to meet and collaborate.

• CLIC collaboration tips, Grant policy issues, opportunities for leadership via CLIC

• What we want to address in the future: Raise enough funds so a person from every CTSA community would have funding for a pre or post doc and a PI from a different institution could work on a collaboration or a publication. Create regular webinars. Creating more opportunities for leadership.

TL1 Survey

In Process

Goal

CONTACT: Wayne T. McCormack, PhDTL1 PI, University of Florida

Creating a TL1 Survey with the goal being to • Determine the breadth of Program

services that are offered

• Develop a "snapshot" of trainee characteristics and goals

• Identify practices that can be shared among the TL1 programs

• Anticipate we should have the survey out next month

TL1 Presentations

CLIC Forum!

Features• Categories

• Allows users to direct posts to a more targeted audience

• Threads• Conversations that happen within a category

• Points• Users are awarded points & badges for different interactions

• Voting• Users can up-vote & down-vote responses to help decide which answers are most useful

• Questions - clic@clic-ctsa.org

CLIC/NCATS Communication ChannelsSharing Content: CLIC Website

News (Consortium News & WOW! Factor stories):

clic-ctsa.org/news

Events: clic-ctsa.org/events

Resources (Resource Center): clic-

ctsa.org/resource-center

Educational tools (Education Clearinghouse): clic-

ctsa.org/education

Funding opportunities (RFAs): clic-ctsa.org/funding-

opps

Career & training opportunities (Opportunities

Board): clic-ctsa.org/opportunities_board

CLIC Forum

Ask the consortium questions, discuss best practices

and share opportunities: clic-ctsa.org/forum

CLIC Activity Stream

A ‘to-the-minute’ stream of the newest content on the

CLIC website, accessible by logging in

Twitter NCATS: twitter.com/ncats_nih_gov

CLIC: twitter.com/CLIC_CTSA

Hashtag: #CTSAProgram

CLIC Suggestion Box

Suggest topics of interest for discussion: clic-

ctsa.org/contact/suggestion-box

CLIC Contact Us

Have a question and not sure where to direct it?:

clic-ctsa.org/contact

Newsletters CTSA Ansible: clic-ctsa.org/newsletter-

signup/5ed5d33016

CLIC News Roundup: clic-ctsa.org/newsletter-signup/0c3e7d6ba9

NCATS e-Newsletter: ncats.nih.gov/enews

CTSA Program Initiative Channels

ACT Network

Website: http://www.actnetwork.us/National

Subscribe to newsletter:

https://bit.ly/2HQGsM5

IREx

Website: https://www.irbexchange.org

Subscribe to newsletter: https://bit.ly/2TtQG7b

National Center for Data to Health

(CD2H)

Website: http://www.actnetwork.us/National

Subscribe to newsletter:

https://bit.ly/2HQGsM5

Recruitment Innovation Center (RIC)

Website:

https://trialinnovationnetwork.org/recruitment-

innovation-center

Subscribe to newsletter:

https://bit.ly/2OpEDHc

SMART IRB

Website: https://smartirb.org

Subscribe to newsletter: https://bit.ly/2JFbiK3

Trial Innovation Network (TIN)

Website: https://trialinnovationnetwork.org

Subscribe to newsletter:

https://bit.ly/2TXHQDZ

Reminders

• Our next CTSA Program Webinar will be held on Wednesday, April

24, 2019 at 2:00 PM Eastern Time

• Registration URL:

https://rochester.zoom.us/webinar/register/WN_J955FmN9R_inqw1-

nTb-4w